Biotechnology & Medical Research

Lion Biotechnologies names Elma Hawkins president

Lion Biotechnologies:Announces that it has hired Elma Hawkins, to serve as president and chief operating officer.Appointment is effective immediately.

4:05pm EDT

Kindred Biosciences Inc announces top-line results from pivotal study of CereKin in dogs with Osteoarthritis

Kindred Biosciences Inc:Says that pivotal field study (KB010) of CereKin, interleukin-1 inhibitor for control of pain and inflammation associated with osteoarthritis in dogs, did not meet primary endpoint.Randomized, double-blind, placebo-controlled study evaluated safety and efficacy of two doses...

4:01pm EDT

Veloxis Pharmaceuticals A/S maintains FY 2014 guidance

Veloxis Pharmaceuticals A/S:Maintains FY 2014 outlook with an operating loss of 60-90 million Danish crowns and a net loss of 55-85 million Danish crowns for FY 2014.FY 2014 EBIT of (89.00) million Danish crowns, net income of (85.00) million Danish crowns - Thomson Reuters I/B/E/S.

1:42pm EDT

NovaBay announces results of NVC-422 phase 2 for Viral Conjunctivitis

NovaBay Pharmaceuticals Inc:Says its NVC-422 ophthalmic formulation did not meet the primary or secondary endpoints in a Phase 2 clinical study in patients with adenoviral conjunctivitis.Trial was a global, multi-centered, randomized study that enrolled patients with adenoviral conjunctivitis in the...

7:00am EDT

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.